| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Budge James | Chief Financial Officer | C/O HINGE HEALTH, INC., 455 MARKET STREET, SUITE 700, SAN FRANCISCO | /s/ David Wood, Attorney-in-Fact | 23 May 2025 | 0001338176 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HNGE | Common Stock | Award | $0 | +91,875 | +15% | $0.000000 | 694,440 | 29 Apr 2025 | Direct | F1, F2 |
| transaction | HNGE | Common Stock | Tax liability | $4,322,240 | -135,070 | -19% | $32.00 | 559,370 | 21 May 2025 | Direct | |
| transaction | HNGE | Common Stock | Other | -559,370 | -100% | 0 | 23 May 2025 | Direct | F3 | ||
| transaction | HNGE | Class A Common Stock | Other | +559,370 | 559,370 | 23 May 2025 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Reflects an award of restricted stock units ("RSUs"), which vests as to 3.125% of the total award each quarter for the first two years, and as to 9.375% of the total award each quarter thereafter until fully vested at the fourth anniversary of the vesting commencement date. Each RSU represents a contingent right to receive one share of Class A Common Stock following the reclassification of the Issuer's Common Stock. |
| F2 | These securities were previously reported on a Form 3 filed by the Reporting Person. |
| F3 | Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, were reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7. |
| F4 | Includes 387,084 RSUs, which vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock. |